PL2448950T3 - Synteza disodowej soli N4-(2,2-dimetylo-4-[(diwodorofosfonoksy)metylo]-3-okso-5-pyrido[1,4]oksazyn-6-ylo)-5-fluoro-N2-(3,4,5-trimetoksyfenylo)-2,4-pirymidynodiaminy - Google Patents

Synteza disodowej soli N4-(2,2-dimetylo-4-[(diwodorofosfonoksy)metylo]-3-okso-5-pyrido[1,4]oksazyn-6-ylo)-5-fluoro-N2-(3,4,5-trimetoksyfenylo)-2,4-pirymidynodiaminy

Info

Publication number
PL2448950T3
PL2448950T3 PL10730679T PL10730679T PL2448950T3 PL 2448950 T3 PL2448950 T3 PL 2448950T3 PL 10730679 T PL10730679 T PL 10730679T PL 10730679 T PL10730679 T PL 10730679T PL 2448950 T3 PL2448950 T3 PL 2448950T3
Authority
PL
Poland
Prior art keywords
oxazin
trimethoxyphenyl
pyrido
oxo
fluoro
Prior art date
Application number
PL10730679T
Other languages
English (en)
Inventor
Ulfried Felfer
Karl-Heinz Giselbrecht
Michael Wolberg
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of PL2448950T3 publication Critical patent/PL2448950T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL10730679T 2009-07-02 2010-07-01 Synteza disodowej soli N4-(2,2-dimetylo-4-[(diwodorofosfonoksy)metylo]-3-okso-5-pyrido[1,4]oksazyn-6-ylo)-5-fluoro-N2-(3,4,5-trimetoksyfenylo)-2,4-pirymidynodiaminy PL2448950T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27007309P 2009-07-02 2009-07-02
PCT/US2010/040792 WO2011002999A1 (en) 2009-07-02 2010-07-01 Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt
EP10730679.7A EP2448950B1 (en) 2009-07-02 2010-07-01 Synthesis of n4-(2,2-dimethyl-4-[(dihydrogen phosphonoxy)methyl]-3-oxo-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine disodium salt

Publications (1)

Publication Number Publication Date
PL2448950T3 true PL2448950T3 (pl) 2016-06-30

Family

ID=42937685

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10730679T PL2448950T3 (pl) 2009-07-02 2010-07-01 Synteza disodowej soli N4-(2,2-dimetylo-4-[(diwodorofosfonoksy)metylo]-3-okso-5-pyrido[1,4]oksazyn-6-ylo)-5-fluoro-N2-(3,4,5-trimetoksyfenylo)-2,4-pirymidynodiaminy

Country Status (21)

Country Link
US (3) US8299242B2 (pl)
EP (1) EP2448950B1 (pl)
JP (1) JP5739882B2 (pl)
CN (1) CN102482305B (pl)
AU (1) AU2010266213B2 (pl)
BR (1) BRPI1011888A2 (pl)
CA (1) CA2766801C (pl)
CY (1) CY1117489T1 (pl)
DK (1) DK2448950T3 (pl)
EA (1) EA021657B1 (pl)
ES (1) ES2565985T3 (pl)
HR (1) HRP20160319T1 (pl)
HU (1) HUE027212T2 (pl)
ME (1) ME02388B (pl)
PL (1) PL2448950T3 (pl)
RS (1) RS54679B1 (pl)
SG (1) SG176799A1 (pl)
SI (1) SI2448950T1 (pl)
SM (1) SMT201600084B (pl)
UA (1) UA108077C2 (pl)
WO (1) WO2011002999A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
WO2011106248A2 (en) * 2010-02-24 2011-09-01 Auspex Pharmaceuticals, Inc. Trimethoxyphenyl inhibitors of tyrosine kinase
PT2736487T (pt) * 2011-07-28 2019-02-13 Rigel Pharmaceuticals Inc Novas formulações de (trimetoxifenilamino) pirimidinilo
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
CN102746337B (zh) * 2012-06-21 2014-12-17 成都苑东药业有限公司 一种2,4-嘧啶二胺类化合物及其制备方法
US9145411B2 (en) 2012-08-02 2015-09-29 Asana Biosciences, Llc Substituted amino-pyrimidine derivatives
SMT201800644T1 (it) 2013-12-20 2019-01-11 Rigel Pharmaceuticals Inc Processo farmaceutico e intermedi
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
CN110087646A (zh) 2016-09-08 2019-08-02 格利康科技集团有限责任公司 单体双金属羟基柠檬酸化合物及其制备和使用方法
CN111417634A (zh) * 2017-10-04 2020-07-14 细胞基因公司 用于制备顺式-4-[2-{[(3s,4r)-3-氟噁烷-4-基]氨基}-8-(2,4,6-三氯苯胺基)-9h-嘌呤-9-基]-1-甲基环己烷-1-甲酰胺的方法
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US324087A (en) 1885-08-11 Abel combs
US303022A (en) 1884-08-05 Egg-beater
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
AU2003221887A1 (en) 2002-04-12 2003-10-27 Tritek Technologies, Inc. Mail sorting processes and systems
ES2445208T3 (es) 2002-07-29 2014-02-28 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para uso en métodos para tratar o prevenir enfermedades autoinmunitarias
BRPI0413018B8 (pt) 2003-07-30 2021-05-25 Rigel Pharmaceuticals Inc composto, e, uso de um composto
US20060047135A1 (en) 2004-08-30 2006-03-02 Chadwick Scott T Process for preparing chloromethyl di-tert-butylphosphate
DE602006010979D1 (de) * 2005-01-19 2010-01-21 Rigel Pharmaceuticals Inc Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
JP4981673B2 (ja) * 2005-09-13 2012-07-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 安定性が改善されたクロロメチルフォスフェイト誘導体を含む組成物およびその製造方法
EP2420505A1 (en) * 2006-11-21 2012-02-22 Rigel Pharmaceuticals, Inc. Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну

Also Published As

Publication number Publication date
BRPI1011888A2 (pt) 2016-04-12
US20110003986A1 (en) 2011-01-06
WO2011002999A1 (en) 2011-01-06
HUE027212T2 (en) 2016-10-28
ES2565985T3 (es) 2016-04-08
EP2448950B1 (en) 2016-01-13
JP2012532143A (ja) 2012-12-13
HK1169996A1 (zh) 2013-02-15
CA2766801C (en) 2018-03-13
AU2010266213B2 (en) 2015-06-18
CN102482305B (zh) 2016-07-13
EP2448950A1 (en) 2012-05-09
HRP20160319T1 (hr) 2016-04-22
JP5739882B2 (ja) 2015-06-24
DK2448950T3 (en) 2016-04-04
ME02388B (me) 2016-09-20
US20130018185A1 (en) 2013-01-17
SMT201600084B (it) 2016-04-29
AU2010266213A1 (en) 2012-02-02
CA2766801A1 (en) 2011-01-06
CY1117489T1 (el) 2017-04-26
US20130274499A1 (en) 2013-10-17
EA021657B1 (ru) 2015-08-31
SI2448950T1 (sl) 2016-05-31
US8299242B2 (en) 2012-10-30
UA108077C2 (xx) 2015-03-25
US8481724B2 (en) 2013-07-09
US8691798B2 (en) 2014-04-08
SG176799A1 (en) 2012-01-30
RS54679B1 (sr) 2016-08-31
EA201270114A1 (ru) 2012-05-30
CN102482305A (zh) 2012-05-30

Similar Documents

Publication Publication Date Title
PL2448950T3 (pl) Synteza disodowej soli N4-(2,2-dimetylo-4-[(diwodorofosfonoksy)metylo]-3-okso-5-pyrido[1,4]oksazyn-6-ylo)-5-fluoro-N2-(3,4,5-trimetoksyfenylo)-2,4-pirymidynodiaminy
DK3308769T3 (da) Fremgangsmåder til fremstilling af cykliske lipidimplantater til intraokulær anvendelse
BRPI0818012A2 (pt) Dispositivo de enchimento de um implante cirúrgico
DK2248488T3 (da) Anterior stabiliseret knæimplantat
ZA201002356B (en) Xinafoate salt of n4-(2,2-difluoro-4h-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3-(methylaminocar bonylmethyleneoxy)phenyl]2,4-pyrimidinediamine
BR112012000885A2 (pt) composições de fosfito estáveis hidroliticamente.
TN2011000291A1 (en) Purine compounds
EP2229939A4 (en) CAPSULE FORMULATION
BRPI0813563A2 (pt) Implante de tecido ósseo compreendendo íons de estrôncio
MY159358A (en) Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
BRPI1008498A2 (pt) Composto, prodroga do composto, medicamento, e, uso de um composto.
EP2609064A4 (en) PHARMACEUTICAL COMPOSITIONS WITH POH DERIVATIVES
EP2157864A4 (en) STABILIZED PICOPLATIN DOSAGE FORM
CR20130602A (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa
IL233296A0 (en) Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione
EP2462115A4 (en) ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS
PL2770844T3 (pl) Pochodząca z pomidorów kompozycja zawierająca zwiększone poziomy 5’-monofosforanu inozyny
PL1864668T3 (pl) Wykorzystanie proleku do okulistycznego podawania śródszklistkowego
PA8717801A1 (es) Formulaciones farmaceuticas de una forma cristalina de monohidrato de 2-(3-fluor-4-hidroxifenil)-7-vinil-1,3-benzoxazol-5-ol
EP2114418A4 (en) ORAL DOSAGE FORM WITH STABILIZED PICOPLATIN
BRPI0923675A8 (pt) formulação para a administração de hipolipemiantes por via transmucosa oral
BR112012000758A2 (pt) composições líquidas de fosfito tendo grupos alquila diferentes
FR2978658B1 (fr) Implant de fixation dynamique intervertebral
BRPI0719791A2 (pt) Transportador de implante dentário
IT1400009B1 (it) Struttura di supporto per la realizzazione di strumenti per protesi dentali